Summary: Current evidence does not establish a definitive causal relationship between weight loss injections (GLP-1 receptor agonists) and pancreatitis, though UK regulatory guidance lists pancreatitis as a potential adverse effect requiring monitoring
In a study in subjects with different degrees of hepatic impairment, no clinically relevant change in semaglutide pharmacokinetics was observed [see Clinical Pharmacology (12.3)]
The peptide is made with a specific amino acid sequence to ensure stability and consistency during research
For people whose sleep apnea is severe enough to affect daily functioning, the greater weight loss from tirzepatide or potentially retatrutide could be a deciding factor in medication choice
The active ingredient in Mounjaro, tirzepatide, works by activating two naturally produced hormones in the body: glucagon-like peptide-1, known as GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP
By week 12 your body looks different